Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic Sclerosis
A multicenter clinical trial is investigating AI-based screening models for detecting pulmonary arterial hypertension in patients with syste…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: The Effect of Slow-Paced Breathing on Patient Outcomes in Pulmonary Arterial Hypertension [NA]
A completed study from Ege University evaluated whether slow-paced breathing impacts outcomes in patients with pulmonary arterial hypertensi…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Pulmonary Vascular Disease Phenomics Program PVDOMICS
Clinical trial registry update for the Pulmonary Vascular Disease Phenomics Program (PVDOMICS) sponsored by The Cleveland Clinic. The study …
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Pulmonary Hypertension Association Registry
A registry trial entry opened for recruitment under the Pulmonary Hypertension Association Registry, studying patients with pulmonary arteri…
-
FDA approval · 2025-11-05FDA Approved: TRACLEER — Supplemental Application (Actelion Pharmaceuticals US, Inc.)
The FDA approved a supplemental application for Tracleer (bosentan) submitted by Actelion, resulting in an update to the product's labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2025-11-05FDA Approved: TRACLEER — Supplemental Application (Actelion Pharmaceuticals US, Inc.)
FDA approved a supplemental application for Tracleer (bosentan) submitted by Actelion Pharmaceuticals US, Inc., approving changes to the dru…
-
FDA approval · 2025-11-05FDA Approved: BOSENTAN — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for bosentan submitted by Actavis Pharma, Inc.
-
FDA approval · 2025-11-05FDA Approved: BOSENTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for a generic bosentan (ANDA213154).
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Effects of DHEA in Pulmonary Hypertension [Phase 2]
A Phase 2 trial evaluating the effects of dehydroepiandrosterone (DHEA) in patients with pulmonary arterial hypertension has completed and r…
-
FDA approval · 2025-11-05FDA Approved: BOSENTAN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved Zydus Pharmaceuticals USA Inc.'s supplemental application for Bosentan, authorizing a generic version of the drug in the U.…
-
FDA approval · 2025-11-05FDA Approved: BOSENTAN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' supplemental application for bosentan, enabling the generic bosentan product to proceed.
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Rutgers University Study of the Genetics of Pulmonary Hypertension
Rutgers University is conducting a genetics study on pulmonary hypertension and related subtypes, currently recruiting participants.
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension [Phase 3]
A Phase 3 trial evaluating macitentan in Japanese pediatric participants with pulmonary arterial hypertension has completed and posted resul…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Xenon MRI Pulm Hypertension [Phase 2]
A Phase 2 clinical trial evaluating Xenon MRI for pulmonary hypertension and pulmonary arterial hypertension is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension [Phase 1]
Phase 1 clinical trial assessing the safety, feasibility, and pharmacokinetics of microbiota transplant therapy with antibiotic precondition…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Sildenafil for Early Pulmonary Vascular Disease in Scleroderma [Phase 2]
A Phase 2 clinical trial evaluating sildenafil for early pulmonary vascular disease in patients with systemic sclerosis (scleroderma) is cur…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Safety and Efficacy of Nebulized Nitroglycerin in Pulmonary Arterial Hypertension [NA]
A completed study evaluating the safety and efficacy of nebulized nitroglycerin in patients with pulmonary arterial hypertension.
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia [Phase 2, Phase 3]
Phase 2/3 trial evaluating the effect of L-glutamine on pulmonary arterial pressure in patients with non-transfusion-dependent thalassemia. …
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Information Sources in Pulmonary Hypertension
A ClinicalTrials.gov entry describes a study at University of Sao Paulo General Hospital focusing on information sources in Pulmonary Arteri…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension. [Phase 4]
This document describes a Phase 4 long-term extension study of riociguat in patients with symptomatic pulmonary arterial hypertension. It ai…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Safety and Efficacy of Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension [NA]
A completed clinical trial assesses safety and efficacy of pulmonary artery denervation for pulmonary arterial hypertension.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension
This clinical trial update describes a study assessing the impact of switching endothelin receptor antagonists on risk stratification in pul…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study). [Phase 2]
A Phase 2 trial evaluating KER-012 in combination with background therapy for adults with pulmonary arterial hypertension has completed, ass…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch
A national cohort research study led by University of Sao Paulo General Hospital is currently recruiting to investigate pulmonary arterial h…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System [NA]
Update on a clinical trial evaluating the Aria CV Pulmonary Hypertension System for pulmonary arterial hypertension and related right-heart …